CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.32 Million USD | -1.47% |
| 2022 | 1.33 Million USD | -31.56% |
| 2021 | 1.95 Million USD | -48.23% |
| 2020 | 3.78 Million USD | 7.18% |
| 2019 | 3.52 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 442.28 Thousand USD | -43.93% |
| 2024 Q1 | 788.87 Thousand USD | -40.24% |
| 2023 FY | 1.32 Million USD | -1.47% |
| 2023 Q2 | 614.53 Thousand USD | -29.44% |
| 2023 Q1 | 870.93 Thousand USD | -34.99% |
| 2023 Q3 | 355.1 Thousand USD | -42.22% |
| 2023 Q4 | 1.32 Million USD | 271.74% |
| 2022 Q3 | 437.97 Thousand USD | -52.74% |
| 2022 Q4 | 1.33 Million USD | 205.89% |
| 2022 Q2 | 926.65 Thousand USD | -35.02% |
| 2022 Q1 | 1.42 Million USD | -27.15% |
| 2022 FY | 1.33 Million USD | -31.56% |
| 2021 FY | 1.95 Million USD | -48.23% |
| 2021 Q1 | 1.81 Million USD | -52.02% |
| 2021 Q2 | 1.63 Million USD | -9.94% |
| 2021 Q3 | 412.63 Thousand USD | -74.75% |
| 2021 Q4 | 1.95 Million USD | 374.4% |
| 2020 Q4 | 3.78 Million USD | 39.0% |
| 2020 Q3 | 2.72 Million USD | -19.79% |
| 2020 Q2 | 3.39 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 3.78 Million USD | 7.18% |
| 2019 FY | 3.52 Million USD | 0.0% |
| 2019 Q4 | 3.52 Million USD | 42.85% |
| 2019 Q3 | 2.47 Million USD | 1666.27% |
| 2019 Q2 | 139.84 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BIMI International Medical Inc. | 5.45 Million USD | 75.802% |
| China Jo-Jo Drugstores, Inc. | 43.21 Million USD | 96.946% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 99.307% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 99.279% |
| Leafly Holdings, Inc. | 29.08 Million USD | 95.461% |
| Leafly Holdings, Inc. | 29.08 Million USD | 95.461% |
| LifeMD, Inc. | 18.93 Million USD | 93.027% |
| LifeMD, Inc. | 18.93 Million USD | 93.027% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | 81.418% |
| PetMed Express, Inc. | 1.45 Million USD | 9.211% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 99.986% |